ESS Tech (GWH) 10-Q/A 3 Dec 21 2021 Q1 Quarterly report (amended) Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2021	Nov. 30, 2021
Document Information [Line Items]
Document Type	10-Q/A
Amendment Flag	true
Document Quarterly Report	true
Document Transition Report	false
Entity Registrant Name	ESS TECH, INC.
Entity Central Index Key	0001819438
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Incorporation, State or Country Code	DE
Document Period End Date	Mar. 31, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Entity Shell Company	false
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity File Number	001-39525
Entity Tax Identification Number	98-1550150
Entity Address, Address Line One	6440 SW Parkway Ave.
Entity Address, Address Line Two	Bldg. 83
Entity Address, City or Town	Wilsonville
Entity Address, State or Province	OR
Entity Address, Postal Zip Code	97070
City Area Code	855
Local Phone Number	423-9920
Entity Common Stock, Shares Outstanding		144,675,733
Amendment Description	ESS Tech, Inc., a Delaware corporation (“ESS” or the “Company”), Formerly ACON S2 Acquisition Corp. (“STWO”), is filing this Amendment No. 1 on Form 10-Q/A (the “Amendment No. 1”) to amend and restate certain items in its Quarterly Report on Form 10-Q as of and for the three months ended March 31, 2021, originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on May 24, 2021 (the “Original Filing”). We restated our audited financial statements as of and for the period from July 21, 2020 (inception) through December 31, 2020, which restatement was effective with the filing of our Amended Annual Report on Form 10-K as filed on December 2, 2021. This Amendment No. 1 is presented as of the filing date of the Original Filing and does not reflect events occurring after that date, or modify or update disclosures in any way other than as required to reflect the restatement as described below. Accordingly, this Amendment No. 1 should be read in conjunction with our filings with the SEC subsequent to the date on which we filed the Original Filing. The Company is filing this Amendment No. 1 to reflect a restatement of the Company’s condensed financial statements as of and for the three months ended March 31, 2021 to correct errors in the Company’s classification of public shares as permanent equity as further described below. On October 8, 2021 (the “Closing Date”), the Company consummated the previously announced merger pursuant to that certain Agreement and Plan of Merger, dated May 6, 2021 (the “Merger Agreement”), by and among STWO, SCharge Merger Sub, Inc., a Delaware corporation and wholly owned direct subsidiary of STWO (“Merger Sub”), and ESS Subsidiary Tech, Inc., a Delaware corporation (formerly known as ESS Tech, Inc.) (“Legacy ESS”) following the approval at a special meeting of the stockholders of STWO held on October 5, 2021 (the “Special Meeting”). Pursuant to the terms of the Merger Agreement, STWO deregistered by way of continuation under the Cayman Islands Companies Act (2021 Revision) and registered as a corporation in the State of Delaware under Part XII of the Delaware General Corporation Law (the “Domestication”), and a business combination between STWO and Legacy ESS was effected through the merger of Merger Sub with and into Legacy ESS, with ESS surviving as a wholly owned subsidiary of STWO (together with the other transactions described in the Merger Agreement, the “Business Combination”). On the Closing Date, the registrant changed its name from “ACON S2 Acquisition Corp.” to “ESS Tech, Inc.” Unless stated otherwise, this report contains information about STWO prior to the Business Combination. References to the “Company” in this report refer to STWO before the Business Combination or ESS after the Business Combination, as the context suggests.
Class A Ordinary Share
Document Information [Line Items]
Title of 12(b) Security	Common Stock, $0.0001 par value per share
Trading Symbol	GWH
Security Exchange Name	NYSE
Redeemable Warrants
Document Information [Line Items]
Title of 12(b) Security	Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 Shares
Trading Symbol	GWH.W
Security Exchange Name	NYSE

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current assets:
Cash	$ 321,774	$ 470,073
Prepaid expenses	244,592	215,972
Total current assets	566,366	686,045
Other assets	88,866	136,991
Cash equivalents held in Trust Account	250,008,147	250,004,454
Total Assets	250,663,379	250,827,490
Current liabilities:
Accounts payable	43,728
Accrued expenses	103,175	99,107
Accrued expenses - related party	70,000	40,000
Total current liabilities	216,903	139,107
Deferred underwriting commissions	8,750,000	8,750,000
Derivative warrant liabilities	11,873,530	21,354,400
Total liabilities	20,840,433	30,243,507
Commitments and Contingencies
Class A ordinary shares 25,000,000 shares subject to possible redemption at $10.00 per share at September 30, 2021 and December 31, 2020, respectively	250,000,000	250,000,000
Shareholders' Deficit:
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
Additional paid-in capital	0	0
Accumulated deficit	(20,177,679)	(29,416,642)
Total shareholders' deficit	(20,177,054)	(29,416,017)
Total Liabilities and Shareholders' Deficit	250,663,379	250,827,490
Class A Ordinary Share
Shareholders' Deficit:
Ordinary shares	0	0
Class B Ordinary Share
Shareholders' Deficit:
Ordinary shares	$ 625	$ 625

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2021	Dec. 31, 2020
Temporary equity, redemption price per share	$ 10
Preferred shares, par value	$ 0.0001	$ 0.0001
Preferred shares, authorized	5,000,000	5,000,000
Preferred shares, issued	0	0
Preferred shares, outstanding	0	0
Class A Ordinary Share
Temporary equity, redemption price per share	$ 10	$ 10
Temporary equity, shares outstanding	25,000,000	25,000,000
Ordinary shares, par value	$ 0.0001	$ 0.0001
Ordinary shares, authorized	500,000,000	500,000,000
Class B Ordinary Share
Ordinary shares, par value	$ 0.0001	$ 0.0001
Ordinary shares, authorized	50,000,000	50,000,000
Ordinary shares, issued	6,250,000	6,250,000
Ordinary shares, outstanding	6,250,000	6,250,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS	3 Months Ended
	Mar. 31, 2021USD ($)$ / sharesshares
Operating expenses
General and administrative expenses	$ 245,600
Loss from operations	(245,600)
Other income (expense)
Change in fair value of derivative warrant liabilities	9,480,870
Gain on marketable securities (net), and dividends held in Trust Account	3,693
Total other income (expense)	9,484,563
Net income	$ 9,238,963
Shares Subject to Redemption
Other income (expense)
Weighted average shares outstanding of basic and diluted | shares	25,000,000
Basic and diluted net loss per share | $ / shares	$ 0.30
Class B Ordinary Share
Other income (expense)
Weighted average shares outstanding of basic and diluted | shares	6,250,000
Basic and diluted net loss per share | $ / shares	$ 0.30

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - 3 months ended Mar. 31, 2021 - USD ($)	Total	Accumulated Deficit [Member]	Additional Paid-In Capital [Member]	Class A Ordinary ShareCommon Stock [Member]	Class B Ordinary ShareCommon Stock [Member]
Beginning Balance, Shares at Dec. 31, 2020				0	6,250,000
Beginning Balance, Value at Dec. 31, 2020	$ (29,416,017)	$ (29,416,642)	$ 0	$ 0	$ 625
Net income (loss)	9,238,963	9,238,963
Ending Balance, Shares at Mar. 31, 2021				0	6,250,000
Ending Balance, Value at Mar. 31, 2021	$ (20,177,054)	$ (20,177,679)	$ 0	$ 0	$ 625

CONDENSED STATEMENT OF CASH FLO

CONDENSED STATEMENT OF CASH FLOWS	3 Months Ended
	Mar. 31, 2021USD ($)
Cash Flows from Operating Activities:
Net income	$ 9,238,963
Adjustments to reconcile net loss to net cash used in operating activities:
Gain on marketable securities (net), and dividends held in Trust Account	(3,693)
Change in fair value of derivative warrant liabilities	(9,480,870)
Changes in operating assets and liabilities:
Prepaid expenses and other assets	19,505
Accounts payable	43,728
Accrued expenses	4,068
Accrued expenses - related party	30,000
Net cash used in operating activities	(148,299)
Net decrease in cash	(148,299)
Cash - beginning of the period	470,073
Cash - ending of the period	$ 321,774

Description of Organization, Bu

Description of Organization, Business Operations and Basis of Presentation	3 Months Ended
	Mar. 31, 2021
Description Of Organization Business Operations And Basis Of Presentation [Abstract]
Description of Organization, Business Operations and Basis of Presentation	Note 1—Description of Organization, Business Operations and Basis of Presentation ESS Tech, Inc., formerly known as ACON S2 Acquisition Corp. (the “Company”), is a blank check company incorporated as a Cayman Islands exempted company on July , . The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with or more businesses that the Company has not yet identified (“Business Combination”). While the Company may pursue a Business Combination opportunity in any business, industry, sector or geographical location, management intends to initially focus the search on identifying a prospective target business that employs a strategic approach to sustainability; that is, a business whose pursuit of sustainability environmental, social and/or economic is core to driving its performance and success. The Company is an “emerging growth company,” as defined in Section (a) of the Securities Act of , as amended (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of (the “JOBS Act”). As of March 31, 2021, the Company had not yet commenced operations. All activity for the period from July 21, 2020 (inception) through March 31, 2021 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”), which is described below, and, since the closing of the Initial Public Offering, a search for a business combination candidate. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating The Company’s sponsor is ACON S2 Sponsor, L.L.C., a Delaware limited liability company (“Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on September 16, 2020. On September 21, 2020, the Company consummated its Initial Public Offering of 25,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $250.0 million, and incurring offering costs of approximately $14.4 million, inclusive of approximately $8.8 million in deferred underwriting commissions (Note 7). The underwriters were granted a 45-day option from Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 4,666,667 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $1.50 per Private Placement Warrant with our Sponsor, generating gross proceeds of $7.0 million (Note 5). Upon the closing of the Initial Public Offering and the Private Placement, $250.0 million ($10.00 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement were placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee and invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the trust account) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended, or the Investment Company Act. The Company will provide its holders of the Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per share, plus any In addition, the Initial Shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. In addition, the Company has agreed not to enter into a definitive agreement regarding an initial Business Combination without the prior consent of our Sponsor. Notwithstanding the foregoing, the Company’s Amended and Restated Memorandum and Articles of Association provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), is restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, executive officers and directors agreed not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association that would affect the substance or timing of the Company’s obligation to provide for the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment. If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or September 21, 2022 (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten (10) business days thereafter, redeem the Public Shares, at a per-share price, The Initial Shareholders agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, our Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act. In the event that an executed waiver is deemed to be unenforceable against a third party, our Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that our Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (exc e e Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the period presented. Operating results for the three months ended March 31, 2021 are not necessarily indicative of the results that may be expected through December 31, 2021. These unaudited condensed financial statements should be read in conjunction with our financial statements and notes thereto and for period from July 21, 2020 (inception) through December 31, 2020, which are included in the Amended Annual Report on Form 10-K/A Dec 2 Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Going concern As of March 31, 2021, the Company had approximately $322,000 in our operating bank account and working capital of approximately $349,000. The Company’s liquidity needs to date have been satisfied through a contribution of $25,000 from the Sponsor to cover certain of the Company’s expenses on our behalf in exchange for the issuance of the Founder Shares, the loan proceeds of $112,000 from the Sponsor pursuant to the Note (see Note 5), and the net proceeds from the consummation of the Private Placement not held in the Trust Account. The Company fully repaid the Note on September 21, 2020. In addition, in order to finance transaction costs in connection with a Business Combination, the Company’s officers, directors and Initial Shareholders may, but are not obligated to, provide the Company a working capital loan. As of March 31, 2021, there were no amounts outstanding under any Working Capital Loan. Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. The Company will need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern until the earlier of the consummation of the Business Combination or the date the Company is required to liquidate, September 22, 2022. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. Risks and Uncertainties In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (COVID-19) COVID-19

Restatement of Financial Statem

Restatement of Financial Statements	3 Months Ended
	Mar. 31, 2021
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Restatement of Financial Statements	Note 2— Restatement of Financial Statements In accordance with ASC 480-10-S99, The following tables contain unaudited quarterly financial information for the quarterly period ended March 31, 2021 that has been updated to reflect the restatement. The restatement had no impact net loss, net cash flows from operating, investing or financing activities. The financial information that has been previously filed or otherwise reported for the quarterly period ended M a for the quarterly period ended March 31, 2021 contained in such previously filed report should no longer be relied upon: As of March 31, 2021 Unaudited Condensed Balance Sheet As Previously Adjustment As Restated Total assets $ 250,663,379 $ 250,663,379 Total liabilities $ 20,840,433 $ 20,840,433 Class A ordinary shares subject to possible redemption 224,822,940 25,177,060 250,000,000 Preference shares — — — Shareholders’ equity Class A ordinary shares 252 (252 ) — Class B ordinary shares 625 — 625 Additional paid-in capital — — — Accumulated deficit 4,999,129 (25,176,808 ) (20,177,679 ) Total shareholders’ equity (deficit) $ 5,000,006 $ (25,177,060 ) $ (20,177,054 ) Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) $ 250,663,379 $ — $ 250,663,379 Three months ended March 31, 2021 Unaudited Statement of Operations As Previously Adjustment As Restated Earnings allocable to ordinary shares subject to possible redemption $ 3,321 $ 7,387,849 $ 7,391,170 Weighted average shares outstanding 21,568,664 3,431,336 25,000,000 Basic and diluted earnings per share $ — $ 0.30 $ 0.30 Earnings allocable to non-redeemable ordinary shares $ 9,235,642 $ (7,387,849 ) $ 1,847,793 Weighted average shares outstanding 9,681,336 (3,431,336 ) 6,250,000 Basic and diluted earnings per share $ 0.95 $ (0.65 ) $ 0.30 For the three months ended March 31,2021 Unaudited Statement of Shareholders’ Deficit As Previously Adjustment As Restated Shares subject to redemption $ (9,238,960 ) $ 9,238,960 $ — Three Months Ended March 31, 2021 Unaudited Statement of Cash Flows As Previously Adjustment As Restated Supplemental Disclosure of Noncash Financing Activities: Change in value of Class A ordinary shares subject to possible redemption $ (9,238,960 ) $ 9,238,960 $ —

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 3—Summary of Significant Accounting Policies Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires the Company’s man a that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of March 31, 2021, the Company did not have any cash equivalents. Cash Equivalents Held in Trust Account Upon the closing of the Initial Public Offering and the Private Placement, $250.0 million of the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement were placed in the Trust Account and invested in money market funds meeting certain conditions under Rule 2a-7 promulgated Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000, and investments held in Trust Account. At March 31, 2021, the Company has not experienced losses on these accounts. Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of March 31, 2021 and December 31, 2020, the carrying values of cash, prepaid expenses, accounts payable, accrued expenses, and franchise tax payable approximate their fair values due to the short-term nature of the instruments. The Company’s investments held in Trust Account are comprised of investments in U.S. Treasury securities with an original maturity of 185 days or less or investments in a money market funds that comprise only U.S. treasury securities and are recognized at fair value. The fair value of investments held in Trust Account is determined using quoted prices in active markets. Derivative warrant liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. re-assessed The 8,333,333 issued in connection with the Initial Public Offering (the “Public Warrants”) and the 4,666,667 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815-40. re-measurement Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at March 31, 2021, 25,000,000 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Immediately upon the closing of the Initial Public Offering, the Company recognized the remeasurement from initial book value to redemption amount. The change in the carrying value of Class A ordinary shares subject to possible redemption resulted in charges against additional paid-in Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Deferred tax assets were deemed immaterial as of March 31, 2021. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2021. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of March 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. Net Loss Per Ordinary Share The Company has two classes of shares, Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the periods. The Company has not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 13,000,000, of the Company’s Class A ordinary shares in the calculation of diluted net income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the periods presented. The remeasurement adjustment associated with the Class A ordinary shares subject to possible redemption is excluded from earnings per share as the redemption value approximates fair value For the three months ended Class A Class B (restated) Basic and diluted net loss per common share: Numerator: Allocation of net loss $ 7,391,170 $ 1,847,793 Denominator: Basic and diluted weighted average common shares outstanding 25,000,000 6,250,000 Basic and diluted net loss per common share $ 0.30 $ 0.30 Recent Adopted Accounting Standards In August 2020, the FASB issued Accounting Standards Update 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) ’ s Own Equity (Subtopic 815-40): ’ s Own Equity 2020-06”), simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 Recent Accounting Standards The Company’s management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect

Initial Public Offering

Initial Public Offering	3 Months Ended
	Mar. 31, 2021
Initial Public Offering [Abstract]
Initial Public Offering	Note 4—Initial Public Offering On September 21, 2020, the Company consummated its Initial Public Offering of 25,000,000 Units, at $10.00 per Unit, generating gross proceeds of $250.0 million, and incurring offering costs of approximately $14.4 million, inclusive of approximately $8.8 million in deferred underwriting commissions.

Private Placement

Private Placement	3 Months Ended
	Mar. 31, 2021
Private Placement [Abstract]
Private Placement	Note 5—Private Placement Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 4,666,667 Private Placement Warrants, at a price of $1.50 per Private Placement Warrant with our Sponsor, generating gross proceeds of $7.0 million. Each whole Private Placement Warrant is exercisable for one whole share of Class A ordinary shares at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to our Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable for Our Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2021
Related Party Transactions [Abstract]
Related Party Transactions	Note 6—Related Party Transactions Founder Shares On July 27, 2020, our Sponsor paid an aggregate of $25,000 for certain expenses on behalf of the Company in exchange for issuance of 7,187,500 Class B ordinary shares (the “Founder Shares”). The holders of the Founder Shares agreed to forfeit up to an aggregate of 937,500 Founder Shares, on a pro rata basis, to the extent that the option to purchase additional units is not exercised in full by the underwriters, so that the Founder Shares will represent 20% of the Company’s issued and outstanding shares after the Initial Public Offering. The over-allotment option expired unexercised on October 31, 2020, thus the 937,500 of Class B ordinary shares were forfeited. The Initial Shareholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day Related Party Loans On July 27, 2020, our Sponsor agreed to loan the Company up to $300,000 to be used for the payment of costs related to the Initial Public Offering pursuant to a promissory note (the “Note”). The Note was non-interest bearing, In addition, in order to finance transaction costs in connection with a Business Combination, our Sponsor, members of the Company’s founding team or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. To date, the Company had no borrowings under the Working Capital Loans. Administrative Services Agreement The Company entered into an agreement providing that, commencing on September 16, 2020 through the earlier of consummation of the initial Business Combination and the liquidation, the Company will pay our Sponsor $10,000 per month for office space, secretarial and administrative services provided to the Company. In addition, our Sponsor, executive officers and directors, and any of their respective affiliates will be reimbursed for any out-of-pocket expenses

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 7—Commitments and Contingencies Registration and Shareholder Rights The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration and shareholder rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option The underwriters were entitled to an underwriting discount of $0.20 per unit, or $5.0 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $8.8 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Shareholders' Equity

Shareholders' Equity	3 Months Ended
	Mar. 31, 2021
Equity [Abstract]
Shareholders' Equity	Note 8—Shareholders’ Equity Preference Shares Class A Ordinary Shares C Class B Ordinary Shares Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Except as described below, holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law. The Class B ordinary shares will automatically convert into Class A ordinary shares (which such Class A ordinary shares delivered upon conversion will not have redemption rights or be entitled to liquidating distributions from the Trust Account if the Company does not consummate an initial business combination) at the time of the initial Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, than one-to-one .

Derivative Warrant Liabilities

Derivative Warrant Liabilities	3 Months Ended
	Mar. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Warrant Liabilities	Note 9—Derivative Warrant Liabilities As of March 31, 2021, there were 21,118,750 total warrants outstanding, of which the Company has 8,333,333 and 4,666,667 Public Warrants and Private Placement Warrants, respectively. Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permit holders to exercise their warrants on a cashless basis under certain circumstances). The Company has agreed that as soon as practicable, but in no event later than twenty (20) business days after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC and have an effective registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to our Sponsor or its affiliates, without taking into account any Founder Shares held by our Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable so Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00: • in whole and not in part; • at a price of $0.01 per warrant; • upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and • if, and only if, the last reported sale price (the “closing price”) of Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00: • in whole and not in part; • at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided • if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per Public Share (as adjusted) for any 20 trading days within the 30-trading day • if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading day The “fair market value” of Class A ordinary shares for the above purpose shall mean the volume weighted average price of Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment). In no event will the Company be required to net cash settle any warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 10— Fair Value Measurements The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of March 31, 2021 and December 31, 2020 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. March 31, 2021 Quoted Significant Significant Description (Level 1) (Level 2) (Level 3) Assets: U.S. Treasury securities $ 250,008,147 $ — $ — Liabilities: Warrant liabilities – Public warrants $ 7,590,000 $ — $ — Warrant liabilities – Private warrants $ — $ — $ 4,283,530 December 31, 2020 Quoted Significant Significant Description (Level 1) (Level 2) (Level 3) Assets: U.S. Treasury securities $ 250,004,454 $ — $ — Liabilities: Warrant liabilities – Public warrants $ 13,625,000 $ — $ — Warrant liabilities – Private warrants $ — $ — $ 7,729,400 Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. There were no transfers from a Level 3 measurement to a Level 1 fair value measurement for the three months ended March 2021. Level 1 instruments include investments in mutual funds invested in government securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value of its investments. The fair value of warrants issued in connection with the Initial Public Offering were initially measured at fair value using a Monte Carlo simulation model and have subsequently been measured based on the listed market price of such warrants, a Level 1 measurement, since March 2021. The fair value of the Private Placement warrants have been estimated using a modified Black-Scholes-Merton model at inception and subsequently at each measurement date. For the three months ended March 31, 2021, the Company recognized a charge to the statement of operations resulting from an decrease in the fair value of liabilities of $9.5 million presented as change in fair value of derivative warrant liabilities on the accompanying unaudited condensed statement of operations. The estimated fair value of the Private Placement Warrants, and the Public Warrants prior to being separately listed and traded, is determined using Level 3 inputs. Inherent in a Monte Carlo simulation and modified Black_Scholes_Merton models are assumptions related to expected stock-price volatility, expected life, risk-free interest rate, dividend yield and probability of a successful acquisition. The Company estimates the volatility of its ordinary shares warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s ordinary shares that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates: As of March 31, As of Stock price $ 9.81 $ 10.08 Volatility 10.0 % 10.0 % Expected life of the options to convert 5.7 5.9 Risk-free rate 1.10 % 0.48 % Dividend yield — — The change in the fair value of the derivative warrant liabilities for the period for the three months ended March 31, 2021 is summarized as follows: Derivative warrant liabilities at December 31, 2020 $ 21,354,400 Change in fair value of derivative warrant liabilities (9,480,870 ) Derivative warrant liabilities at March 31, 2021 $ 11,873,530

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2021
Subsequent Events [Abstract]
Subsequent Events	Note 11—Subsequent Events Management has evaluated subsequent events and transactions that occurred after the balance sheet date through the date the balance sheet was available for issuance. Based upon this review, except as noted above, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires the Company’s man a
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of March 31, 2021, the Company did not have any cash equivalents.
Cash Equivalents Held in Trust Account	Cash Equivalents Held in Trust Account Upon the closing of the Initial Public Offering and the Private Placement, $250.0 million of the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement were placed in the Trust Account and invested in money market funds meeting certain conditions under Rule 2a-7 promulgated
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000, and investments held in Trust Account. At March 31, 2021, the Company has not experienced losses on these accounts.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of March 31, 2021 and December 31, 2020, the carrying values of cash, prepaid expenses, accounts payable, accrued expenses, and franchise tax payable approximate their fair values due to the short-term nature of the instruments. The Company’s investments held in Trust Account are comprised of investments in U.S. Treasury securities with an original maturity of 185 days or less or investments in a money market funds that comprise only U.S. treasury securities and are recognized at fair value. The fair value of investments held in Trust Account is determined using quoted prices in active markets.
Derivative Warrant Liabilities	Derivative warrant liabilities The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-15. re-assessed The 8,333,333 issued in connection with the Initial Public Offering (the “Public Warrants”) and the 4,666,667 Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815-40. re-measurement
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, at March 31, 2021, 25,000,000 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Immediately upon the closing of the Initial Public Offering, the Company recognized the remeasurement from initial book value to redemption amount. The change in the carrying value of Class A ordinary shares subject to possible redemption resulted in charges against additional paid-in
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under FASB ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Deferred tax assets were deemed immaterial as of March 31, 2021. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2021. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of March 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
Net Loss Per Ordinary Share	Net Loss Per Ordinary Share The Company has two classes of shares, Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the periods. The Company has not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 13,000,000, of the Company’s Class A ordinary shares in the calculation of diluted net income (loss) per share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the periods presented. The remeasurement adjustment associated with the Class A ordinary shares subject to possible redemption is excluded from earnings per share as the redemption value approximates fair value For the three months ended Class A Class B (restated) Basic and diluted net loss per common share: Numerator: Allocation of net loss $ 7,391,170 $ 1,847,793 Denominator: Basic and diluted weighted average common shares outstanding 25,000,000 6,250,000 Basic and diluted net loss per common share $ 0.30 $ 0.30
Recent Adopted Accounting Standards	Recent Adopted Accounting Standards In August 2020, the FASB issued Accounting Standards Update 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) ’ s Own Equity (Subtopic 815-40): ’ s Own Equity 2020-06”), simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company adopted ASU 2020-06 Recent Accounting Standards The Company’s management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect

Restatement of Financial Stat_2

Restatement of Financial Statements (Tables)	3 Months Ended
	Mar. 31, 2021
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Schedule of Unaudited Quarterly Financial Information for Restatement and Revision	for the quarterly period ended March 31, 2021 contained in such previously filed report should no longer be relied upon: As of March 31, 2021 Unaudited Condensed Balance Sheet As Previously Adjustment As Restated Total assets $ 250,663,379 $ 250,663,379 Total liabilities $ 20,840,433 $ 20,840,433 Class A ordinary shares subject to possible redemption 224,822,940 25,177,060 250,000,000 Preference shares — — — Shareholders’ equity Class A ordinary shares 252 (252 ) — Class B ordinary shares 625 — 625 Additional paid-in capital — — — Accumulated deficit 4,999,129 (25,176,808 ) (20,177,679 ) Total shareholders’ equity (deficit) $ 5,000,006 $ (25,177,060 ) $ (20,177,054 ) Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) $ 250,663,379 $ — $ 250,663,379 Three months ended March 31, 2021 Unaudited Statement of Operations As Previously Adjustment As Restated Earnings allocable to ordinary shares subject to possible redemption $ 3,321 $ 7,387,849 $ 7,391,170 Weighted average shares outstanding 21,568,664 3,431,336 25,000,000 Basic and diluted earnings per share $ — $ 0.30 $ 0.30 Earnings allocable to non-redeemable ordinary shares $ 9,235,642 $ (7,387,849 ) $ 1,847,793 Weighted average shares outstanding 9,681,336 (3,431,336 ) 6,250,000 Basic and diluted earnings per share $ 0.95 $ (0.65 ) $ 0.30 For the three months ended March 31,2021 Unaudited Statement of Shareholders’ Deficit As Previously Adjustment As Restated Shares subject to redemption $ (9,238,960 ) $ 9,238,960 $ — Three Months Ended March 31, 2021 Unaudited Statement of Cash Flows As Previously Adjustment As Restated Supplemental Disclosure of Noncash Financing Activities: Change in value of Class A ordinary shares subject to possible redemption $ (9,238,960 ) $ 9,238,960 $ —

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2021
Earnings Per Share, Basic and Diluted [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	For the three months ended Class A Class B (restated) Basic and diluted net loss per common share: Numerator: Allocation of net loss $ 7,391,170 $ 1,847,793 Denominator: Basic and diluted weighted average common shares outstanding 25,000,000 6,250,000 Basic and diluted net loss per common share $ 0.30 $ 0.30

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2021
Fair Value Disclosures [Line Items]
Summary Of Assets And Liabilities Measured On Recurring Basis	The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of March 31, 2021 and December 31, 2020 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. March 31, 2021 Quoted Significant Significant Description (Level 1) (Level 2) (Level 3) Assets: U.S. Treasury securities $ 250,008,147 $ — $ — Liabilities: Warrant liabilities – Public warrants $ 7,590,000 $ — $ — Warrant liabilities – Private warrants $ — $ — $ 4,283,530 December 31, 2020 Quoted Significant Significant Description (Level 1) (Level 2) (Level 3) Assets: U.S. Treasury securities $ 250,004,454 $ — $ — Liabilities: Warrant liabilities – Public warrants $ 13,625,000 $ — $ — Warrant liabilities – Private warrants $ — $ — $ 7,729,400
Summary of Quantitative Information Regarding Level 3 Fair Value Measurements Inputs at Measurement Dates	The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates: As of March 31, As of Stock price $ 9.81 $ 10.08 Volatility 10.0 % 10.0 % Expected life of the options to convert 5.7 5.9 Risk-free rate 1.10 % 0.48 % Dividend yield — —
Summary of Change in Level 3 Fair Value of Derivative Warrant Liabilities	The change in the fair value of the derivative warrant liabilities for the period for the three months ended March 31, 2021 is summarized as follows: Derivative warrant liabilities at December 31, 2020 $ 21,354,400 Change in fair value of derivative warrant liabilities (9,480,870 ) Derivative warrant liabilities at March 31, 2021 $ 11,873,530

Description of Organization, _2

Description of Organization, Business Operations and Basis of Presentation - Additional Information (Details) - USD ($)	Sep. 21, 2020	Mar. 31, 2021	Dec. 31, 2020	Jul. 27, 2020
Description Of Organization Business Operations And Basis Of Presentation [Line Items]
Warrants price per unit		$ 11.50
Proceeds received from private placement	$ 7,000,000
Net proceeds from issuance of initial public offering and private placement	$ 250,000,000
Net proceeds from issuance of initial public offering and private placement, price per share	$ 10
Assets with fair market value equal		80.00%
Temporary equity, redemption price per share		$ 10
Percentage of public shares to redeemed		100.00%
Interest to pay dissolution expenses		$ 100,000
Operating bank accounts		322,000
Working capital		$ 349,000
Target Entity
Description Of Organization Business Operations And Basis Of Presentation [Line Items]
Business combination post transaction company acquires		50.00%
Class A Ordinary Share
Description Of Organization Business Operations And Basis Of Presentation [Line Items]
Temporary equity, redemption price per share		$ 10	$ 10
Percentage of public shares to redeemed		15.00%
Initial Public Offering
Description Of Organization Business Operations And Basis Of Presentation [Line Items]
Issuance of ordinary shares to Sponsor	$ 25,000,000
Units issued, price per unit	$ 10
Proceeds received from initial public offering, gross	$ 250,000,000
Offering costs	14,400,000
Deferred underwriting commissions	8,800,000
Stock issue price		$ 10
Initial Public Offering | Sponsor | Promissory Note
Description Of Organization Business Operations And Basis Of Presentation [Line Items]
Issuance of ordinary shares to Sponsor		$ 25,000
Note payable - related party		$ 112,000		$ 112,000
Over-Allotment Option
Description Of Organization Business Operations And Basis Of Presentation [Line Items]
Issuance of ordinary shares to Sponsor	$ 3,750,000
Units issued, price per unit	$ 10
Private Placement
Description Of Organization Business Operations And Basis Of Presentation [Line Items]
Warrants price per unit	$ 1.50
Warrants issued	4,666,667
Private Placement | Sponsor
Description Of Organization Business Operations And Basis Of Presentation [Line Items]
Warrants issued	4,666,667
Private Placement | Class A Ordinary Share
Description Of Organization Business Operations And Basis Of Presentation [Line Items]
Warrants price per unit	$ 11.50

Restatement of Financial Stat_3

Restatement of Financial Statements - Schedule of Unaudited Quarterly Financial Information for Restatement and Revision of Unaudited Condensed Balance Sheet (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total assets	$ 250,663,379	$ 250,827,490
Liabilities and Equity [Abstract]
Total liabilities	20,840,433	30,243,507
Class A ordinary shares subject to possible redemption	250,000,000	250,000,000
Shareholders' equity
Preference shares
Additional paid-in capital	0	0
Accumulated deficit	(20,177,679)	(29,416,642)
Total shareholders' equity (deficit)	(20,177,054)	(29,416,017)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Equity (Deficit)	250,663,379	250,827,490
Common Class A [Member]
Shareholders' equity
Ordinary shares	0	0
Common Class B [Member]
Shareholders' equity
Ordinary shares	625	$ 625
Previously Reported [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total assets	250,663,379
Liabilities and Equity [Abstract]
Total liabilities	20,840,433
Class A ordinary shares subject to possible redemption	224,822,940
Shareholders' equity
Preference shares	0
Additional paid-in capital	0
Accumulated deficit	4,999,129
Total shareholders' equity (deficit)	5,000,006
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Equity (Deficit)	250,663,379
Previously Reported [Member] | Common Class A [Member]
Shareholders' equity
Ordinary shares	252
Previously Reported [Member] | Common Class B [Member]
Shareholders' equity
Ordinary shares	625
Revision of Prior Period, Adjustment [Member]
Liabilities and Equity [Abstract]
Class A ordinary shares subject to possible redemption	25,177,060
Shareholders' equity
Preference shares	0
Additional paid-in capital	0
Accumulated deficit	(25,176,808)
Total shareholders' equity (deficit)	(25,177,060)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Equity (Deficit)	0
Revision of Prior Period, Adjustment [Member] | Common Class A [Member]
Shareholders' equity
Ordinary shares	(252)
Revision of Prior Period, Adjustment [Member] | Common Class B [Member]
Shareholders' equity
Ordinary shares	0
As Restated [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Total assets	250,663,379
Liabilities and Equity [Abstract]
Total liabilities	20,840,433
Class A ordinary shares subject to possible redemption	250,000,000
Shareholders' equity
Preference shares	0
Additional paid-in capital	0
Accumulated deficit	(20,177,679)
Total shareholders' equity (deficit)	(20,177,054)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Equity (Deficit)	250,663,379
As Restated [Member] | Common Class A [Member]
Shareholders' equity
Ordinary shares	0
As Restated [Member] | Common Class B [Member]
Shareholders' equity
Ordinary shares	$ 625

Restatement of Financial Stat_4

Restatement of Financial Statements - Schedule of Unaudited Quarterly Financial Information for Restatement and Revision of Unaudited Condensed Statement of Operations (Details)	3 Months Ended
	Mar. 31, 2021USD ($)$ / sharesshares
Common Class A [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Weighted average shares outstanding | shares	25,000,000
Basic and diluted earnings per share | $ / shares	$ 0.30
Common Class A [Member] | Previously Reported [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Earnings allocable to ordinary shares subject to possible redemption | $	$ 3,321
Weighted average shares outstanding | shares	21,568,664
Basic and diluted earnings per share | $ / shares	$ 0
Common Class A [Member] | Revision of Prior Period, Adjustment [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Earnings allocable to ordinary shares subject to possible redemption | $	$ 7,387,849
Weighted average shares outstanding | shares	3,431,336
Basic and diluted earnings per share | $ / shares	$ 0.30
Common Class A [Member] | As Restated [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Earnings allocable to ordinary shares subject to possible redemption | $	$ 7,391,170
Weighted average shares outstanding | shares	25,000,000
Basic and diluted earnings per share | $ / shares	$ 0.30
Common Class B [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Weighted average shares outstanding | shares	6,250,000
Basic and diluted earnings per share | $ / shares	$ 0.30
Common Class B [Member] | Previously Reported [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Earnings allocable to ordinary shares subject to possible redemption | $	$ 9,235,642
Weighted average shares outstanding | shares	9,681,336
Basic and diluted earnings per share | $ / shares	$ 0.95
Common Class B [Member] | Revision of Prior Period, Adjustment [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Earnings allocable to ordinary shares subject to possible redemption | $	$ (7,387,849)
Weighted average shares outstanding | shares	(3,431,336)
Basic and diluted earnings per share | $ / shares	$ (0.65)
Common Class B [Member] | As Restated [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Earnings allocable to ordinary shares subject to possible redemption | $	$ 1,847,793
Weighted average shares outstanding | shares	6,250,000
Basic and diluted earnings per share | $ / shares	$ 0.30

Restatement of Financial Stat_5

Restatement of Financial Statements - Schedule of Unaudited Quarterly Financial Information for Restatement and Revision of Unaudited Condensed Statement of Shareholders' Deficit (Details)	3 Months Ended
	Mar. 31, 2021USD ($)
Previously Reported [Member]
Shares subject to possible redemption	$ (9,238,960)
Revision of Prior Period, Adjustment [Member]
Shares subject to possible redemption	9,238,960
As Restated [Member]
Shares subject to possible redemption	$ 0

Restatement of Financial Stat_6

Restatement of Financial Statements - Schedule of Unaudited Quarterly Financial Information for Restatement and Revision of Unaudited Condensed Statement of Cash Flows (Details)	3 Months Ended
	Mar. 31, 2021USD ($)
Previously Reported [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Change in value of Class A ordinary shares subject to possible redemption	$ (9,238,960)
Revision of Prior Period, Adjustment [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Change in value of Class A ordinary shares subject to possible redemption	9,238,960
As Restated [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Change in value of Class A ordinary shares subject to possible redemption	$ 0

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)	Sep. 21, 2020	Mar. 31, 2021	Dec. 31, 2020
Summary Of Significant Accounting Policies [Line Items]
Cash equivalents		$ 0
Assets Held-in-trust, Noncurrent		250,008,147	$ 250,004,454
Concentrations of credit risk federal depository insurance coverage limit		250,000
Unrecognized tax benefits		0
Accrued for payment of interest and penalties		$ 0
Private Placement [Member]
Summary Of Significant Accounting Policies [Line Items]
Warrants issued	4,666,667
Private Placement [Member] | Derivative Liabilities
Summary Of Significant Accounting Policies [Line Items]
Warrants issued		4,666,667
ASU 2020-06
Summary Of Significant Accounting Policies [Line Items]
Change in Accounting Principle, Accounting Standards Update, Adopted [true false]		true
Change in Accounting Principle, Accounting Standards Update, Adoption Date		Jan. 1, 2021
Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]		true
Public Warrants
Summary Of Significant Accounting Policies [Line Items]
Antidilutive securities		13,000,000
Class A Ordinary Shares Subject to Possible Redemption
Summary Of Significant Accounting Policies [Line Items]
Temporary equity shares subject to possible redemption		25,000,000
U.S. Treasury Securities | Public Warrants
Summary Of Significant Accounting Policies [Line Items]
Stock issued during period, shares, new issues		8,333,333
Maximum
Summary Of Significant Accounting Policies [Line Items]
Cash and cash equivalents original maturity term		3 months
Maximum | U.S. Treasury Securities
Summary Of Significant Accounting Policies [Line Items]
Investments held in Trust Account, original maturity		185 days

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of Basic and Diluted Net Income (Loss) per Ordinary Share (Details)	3 Months Ended
	Mar. 31, 2021USD ($)$ / sharesshares
Class A Ordinary Share
Earnings Per Share Basic And Diluted [Line Items]
Allocation of net loss | $	$ 7,391,170
Basic and diluted weighted average common shares outstanding | shares	25,000,000
Basic and diluted net loss per common share | $ / shares	$ 0.30
Class B Ordinary Share
Earnings Per Share Basic And Diluted [Line Items]
Allocation of net loss | $	$ 1,847,793
Basic and diluted weighted average common shares outstanding | shares	6,250,000
Basic and diluted net loss per common share | $ / shares	$ 0.30

Initial Public Offering - Addit

Initial Public Offering - Additional Information (Details) - Initial Public Offering $ / shares in Units, $ in Millions	Sep. 21, 2020USD ($)$ / sharesshares
Initial Public Offering [Line Items]
Number of units issued | shares	25,000,000
Units issued, price per unit | $ / shares	$ 10
Proceeds received from initial public offering, gross	$ 250
Offering costs	14.4
Deferred underwriting commissions	$ 8.8

Private Placement - Additional

Private Placement - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions	Sep. 21, 2020	Mar. 31, 2021
Private Placement [Line Items]
Warrants price per unit		$ 11.50
Private Placement
Private Placement [Line Items]
Warrants issued	4,666,667
Warrants price per unit	$ 1.50
Period to issue warrant after completion of initial business combination		30 days
Private Placement | Sponsor
Private Placement [Line Items]
Warrants issued	4,666,667
Warrants price	$ 1.50
Gross proceeds from private placement	$ 7
Private Placement | Class A Ordinary Share
Private Placement [Line Items]
Warrants price per unit	$ 11.50

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($)	Oct. 31, 2020	Sep. 21, 2020	Sep. 16, 2020	Jul. 27, 2020	Mar. 31, 2021	Dec. 31, 2020
Related Party Transaction [Line Items]
Number of trading days in period					10 days
Warrants price per unit					$ 11.50
Payment of earlier consummation to sponsor			$ 10,000
Accrued expenses for related party					$ 70,000	$ 40,000
Initial Public Offering
Related Party Transaction [Line Items]
Aggregate expenses in issuance of ordinary shares to sponsor		$ 25,000,000
Sponsor
Related Party Transaction [Line Items]
Accrued expenses for related party					70,000
Sponsor | Working Capital Loans [Member]
Related Party Transaction [Line Items]
Warrants price per unit				$ 1.50
Sponsor | Initial Public Offering | Promissory Note
Related Party Transaction [Line Items]
Aggregate expenses in issuance of ordinary shares to sponsor					25,000
Debt face amount				$ 300,000
Note payable - related party				$ 112,000	$ 112,000
Sponsor | Founder Shares
Related Party Transaction [Line Items]
Minimum period for not to transfer, assign or sell of any shares				1 year
Closing price of ordinary shares				$ 12
Number of trading days period commencing after initial business combination				150 days
Sponsor | Minimum | Founder Shares
Related Party Transaction [Line Items]
Number of trading days in period				20 days
Sponsor | Maximum | Working Capital Loans [Member] | Warrants
Related Party Transaction [Line Items]
Debt conversion converted instrument amount				$ 1,500,000
Sponsor | Maximum | Founder Shares
Related Party Transaction [Line Items]
Number of trading days in period				30 days
Class B Ordinary Share
Related Party Transaction [Line Items]
Ordinary shares, issued					6,250,000	6,250,000
Common stock subject to forfeiture					937,500	937,500
Over-allotment expiration date					Oct. 31, 2020
Common stock shares forfeited due to non-exercise of over-allotment option in full or part by underwriters	937,500				937,500
Class B Ordinary Share | Sponsor
Related Party Transaction [Line Items]
Aggregate expenses in issuance of ordinary shares to sponsor				$ 25,000
Ordinary shares, issued				7,187,500
Common stock subject to forfeiture				937,500
Percentage of founder shares representing issued and outstanding shares				20.00%
Over-allotment expiration date				Oct. 31, 2020

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Commitments And Contingencies Disclosure [Line Items]
Deferred underwriting commissions	$ 8,750,000	$ 8,750,000
Underwriting Agreement
Commitments And Contingencies Disclosure [Line Items]
Underwriting discount description	The underwriters were entitled to an underwriting discount of $0.20 per unit, or $5.0 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $8.8 million in the aggregate will be payable to the underwriters for deferred underwriting commissions.
Underwriting discount per unit	$ 0.20
Aggregate underwriting discount	$ 5,000,000
Deferred underwriting discount per unit	$ 0.35
Deferred underwriting commissions	$ 8,800,000
Over Allotment Option Expiration Date	Oct. 31, 2020
Underwriting Agreement | Over-Allotment Option
Commitments And Contingencies Disclosure [Line Items]
Period Granted to Underwriter to Purchase Additional Units	45 days
Underwriting Agreement | Over-Allotment Option | Maximum
Commitments And Contingencies Disclosure [Line Items]
Issuance of ordinary shares to Sponsor, Shares	3,750,000

Shareholders' Equity - Addition

Shareholders' Equity - Additional Information (Details) - USD ($)	Oct. 31, 2020	Mar. 31, 2021	Dec. 31, 2020
Class of Stock [Line Items]
Preferred shares, authorized		5,000,000	5,000,000
Preferred shares, par value		$ 0.0001	$ 0.0001
Preferred shares, issued		0	0
Preferred shares, outstanding		0	0
Common stock voting rights		one vote for each share
Common stock, conversion basis		Class B ordinary shares convert into Class A ordinary shares at a rate of less than one-to-one
Class A Ordinary Share
Class of Stock [Line Items]
Ordinary shares, authorized		500,000,000	500,000,000
Ordinary shares, par value		$ 0.0001	$ 0.0001
Issued or outstanding shares		25,000,000	25,000,000
Class B Ordinary Share
Class of Stock [Line Items]
Ordinary shares, authorized		50,000,000	50,000,000
Ordinary shares, par value		$ 0.0001	$ 0.0001
Ordinary shares, issued		6,250,000	6,250,000
Ordinary shares, outstanding		6,250,000	6,250,000
Common stock subject to forfeiture		937,500	937,500
Underwriters consideration for over allotment		$ 0
Over-allotment expiration date		Oct. 31, 2020
Common stock shares forfeited due to non-exercise of over-allotment option in full or part by underwriters	937,500	937,500
Threshold percentage of founder shares to total shares outstanding		20.00%
Class B Ordinary Share | Founder Shareholders [Member]
Class of Stock [Line Items]
Equity investment, ownership percentage		20.00%

Derivative Warrant Liabilities

Derivative Warrant Liabilities - Additional Information (Details)	3 Months Ended
	Mar. 31, 2021$ / sharesshares
Class of Warrant or Right [Line Items]
Total warrants outstanding | shares	21,118,750
Warrant exercise price	$ 11.50
Minimum share price required for redemption of warrants	$ 18
Public warrants expiration term	5 years
Number of trading days in period	10 days
Percentage of proceeds from share issuances	60.00%
Exercise price adjustment percentage	115.00%
Redemption trigger price adjustment percentage	180.00%
Minimum share price required for redemption of warrants adjustments	$ 10
Ordinary shares per warrant	$ 0.361
Class A Ordinary Share
Class of Warrant or Right [Line Items]
Number of trading days in period	20 days
Ordinary shares redemption period	30 days
Maximum | Business Acquisition
Class of Warrant or Right [Line Items]
Business acquisition, share price	$ 9.20
Public Warrants
Class of Warrant or Right [Line Items]
Total warrants outstanding | shares	8,333,333
Number of trading days in period	20 days
Number of trading days period ending on third business day	30 days
Public Warrants | Class A Ordinary Share
Class of Warrant or Right [Line Items]
Minimum share price required for redemption of warrants adjustments	$ 10
Warrants redemption price per share	$ 0.10
Private Placement Warrants
Class of Warrant or Right [Line Items]
Total warrants outstanding | shares	4,666,667
Number of trading days in period	20 days
Warrants redemption price per share	$ 0.01
Number of trading days period ending on third business day	30 days
Private Placement Warrants | Class A Ordinary Share
Class of Warrant or Right [Line Items]
Number of trading days in period	20 days
Minimum share price required for redemption of warrants adjustments	$ 18
Number of trading days period ending on third business day	30 days

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details)	3 Months Ended
	Mar. 31, 2021USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 3 to Level 1 Transfers, Amount	$ 0
Change in fair value of derivative warrant liabilities	$ (9,480,870)
Expected Dividend Payment
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Alternative Investment, Measurement Input	0
Derivative Liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Change in fair value of derivative warrant liabilities	$ 9,500,000

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Assets and Liabilities Measured on Recurring Basis (Detail) - Fair Value, Recurring - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Fair Value, Inputs, Level 1
Assets:
Investments held in Trust Account	$ 250,008,147	$ 250,004,454
Fair Value, Inputs, Level 1 | Public Warrants
Liabilities:
Liabilities Fair Value Disclosure	7,590,000	13,625,000
Fair Value, Inputs, Level 1 | Private Warrants
Liabilities:
Liabilities Fair Value Disclosure	0	0
Level 2 [Member]
Assets:
Investments held in Trust Account	0	0
Level 2 [Member] | Public Warrants
Liabilities:
Liabilities Fair Value Disclosure	0	0
Level 2 [Member] | Private Warrants
Liabilities:
Liabilities Fair Value Disclosure	0	0
Level 3
Assets:
Investments held in Trust Account	0	0
Level 3 | Public Warrants
Liabilities:
Liabilities Fair Value Disclosure	0	0
Level 3 | Private Warrants
Liabilities:
Liabilities Fair Value Disclosure	$ 4,283,530	$ 7,729,400

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Quantitative Information Regarding Level 3 Fair Value Measurements Inputs at Measurement Dates (Details) - Level 3	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Stock Price
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Alternative Investment, Measurement Input	9.81	10.08
Volatility
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Alternative Investment, Measurement Input	0.100	0.100
Expected Life of the Options to Convert
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Alternative Investment, Measurement Term	5 years 8 months 12 days	5 years 10 months 24 days
Risk-free Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Alternative Investment, Measurement Input	0.0110	0.0048
Dividend yield
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Alternative Investment, Measurement Input	0	0

Fair Value Measurements - Sum_3

Fair Value Measurements - Summary of Change in Level 3 Fair Value of Derivative Warrant Liabilities (Details)	3 Months Ended
	Mar. 31, 2021USD ($)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Beginning balance of derivative warrant liabilities	$ 21,354,400
Change in fair value of derivative warrant liabilities	(9,480,870)
Ending balance of Derivative warrant liabilities	11,873,530
Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Beginning balance of derivative warrant liabilities	21,354,400
Change in fair value of derivative warrant liabilities	(9,480,870)
Ending balance of Derivative warrant liabilities	$ 11,873,530